肾素抑制：肾素-血管紧张素系统阻断的圣杯？ - Suppr

Suppr

超能文献

Renin inhibition: the holy grail of renin-angiotensin system blockade?

作者信息

McInnes G T

机构信息

Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

出版信息

J Hum Hypertens. 2007 Oct;21(10):766-9. doi: 10.1038/sj.jhh.1002221. Epub 2007 May 31.

DOI:10.1038/sj.jhh.1002221

PMID:17541389

Abstract

摘要

相似文献

Renin inhibition: the holy grail of renin-angiotensin system blockade?

J Hum Hypertens. 2007 Oct;21(10):766-9. doi: 10.1038/sj.jhh.1002221. Epub 2007 May 31.

A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.

J Hum Hypertens. 2007 Oct;21(10):780-7. doi: 10.1038/sj.jhh.1002220. Epub 2007 May 31.

[Direct renin inhibition: a new and promising treatment principle in heart failure?].

Dtsch Med Wochenschr. 2009 Apr;134(15):759-62. doi: 10.1055/s-0029-1220227. Epub 2009 Apr 1.

Aliskiren combined with losartan in diabetes and nephropathy.

N Engl J Med. 2008 Sep 4;359(10):1069; author reply 1069-70.

Aliskiren for hypertension in adults.

Drug Ther Bull. 2008 Oct;46(10):73-6. doi: 10.1136/dtb.2008.09.0022.

Aliskiren, the future of renin-angiotensin system blockade?

Expert Rev Cardiovasc Ther. 2007 Sep;5(5):835-49. doi: 10.1586/14779072.5.5.835.

[Renin inhibition and the kidney].

Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 7:28-31.

Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?

Rev Cardiovasc Med. 2006 Spring;7(2):45-54.

Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.

Future Cardiol. 2009 Sep;5(5):453-65. doi: 10.2217/fca.09.31.

[Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].

Dtsch Med Wochenschr. 2012 Nov;137(48):2498. doi: 10.1055/s-0032-1327303. Epub 2012 Nov 20.

引用本文的文献

Diabetic kidney disease: from pathogenesis to multimodal therapy-current evidence and future directions.

Front Med (Lausanne). 2025 Aug 8;12:1631053. doi: 10.3389/fmed.2025.1631053. eCollection 2025.

Mathematical modelling of the influence of polymorphism on blood pressure and antihypertensive therapy.

Heliyon. 2024 Apr 23;10(9):e29988. doi: 10.1016/j.heliyon.2024.e29988. eCollection 2024 May 15.

Mathematical modeling of antihypertensive therapy.

Front Physiol. 2022 Dec 14;13:1070115. doi: 10.3389/fphys.2022.1070115. eCollection 2022.

Reduction of plasma aldosterone and arterial stiffness in obese pre- and stage1 hypertensive subjects after aerobic exercise.

J Hum Hypertens. 2015 Jan;29(1):53-7. doi: 10.1038/jhh.2014.33. Epub 2014 May 1.

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction.

Vasc Health Risk Manag. 2008;4(5):971-81. doi: 10.2147/vhrm.s3215.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Renin inhibition: the holy grail of renin-angiotensin system blockade?

作者信息

McInnes G T

机构信息

Division of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

出版信息

J Hum Hypertens. 2007 Oct;21(10):766-9. doi: 10.1038/sj.jhh.1002221. Epub 2007 May 31.

DOI:10.1038/sj.jhh.1002221

PMID:17541389

Abstract

摘要

相似文献

Renin inhibition: the holy grail of renin-angiotensin system blockade?

J Hum Hypertens. 2007 Oct;21(10):766-9. doi: 10.1038/sj.jhh.1002221. Epub 2007 May 31.

A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension.

J Hum Hypertens. 2007 Oct;21(10):780-7. doi: 10.1038/sj.jhh.1002220. Epub 2007 May 31.

[Direct renin inhibition: a new and promising treatment principle in heart failure?].

Dtsch Med Wochenschr. 2009 Apr;134(15):759-62. doi: 10.1055/s-0029-1220227. Epub 2009 Apr 1.

Aliskiren combined with losartan in diabetes and nephropathy.

N Engl J Med. 2008 Sep 4;359(10):1069; author reply 1069-70.

Aliskiren for hypertension in adults.

Drug Ther Bull. 2008 Oct;46(10):73-6. doi: 10.1136/dtb.2008.09.0022.

Aliskiren, the future of renin-angiotensin system blockade?

Expert Rev Cardiovasc Ther. 2007 Sep;5(5):835-49. doi: 10.1586/14779072.5.5.835.

[Renin inhibition and the kidney].

Turk Kardiyol Dern Ars. 2009 Oct;37 Suppl 7:28-31.

Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?

Rev Cardiovasc Med. 2006 Spring;7(2):45-54.

Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.

Future Cardiol. 2009 Sep;5(5):453-65. doi: 10.2217/fca.09.31.

[Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].

Dtsch Med Wochenschr. 2012 Nov;137(48):2498. doi: 10.1055/s-0032-1327303. Epub 2012 Nov 20.

引用本文的文献

Diabetic kidney disease: from pathogenesis to multimodal therapy-current evidence and future directions.

Front Med (Lausanne). 2025 Aug 8;12:1631053. doi: 10.3389/fmed.2025.1631053. eCollection 2025.

Mathematical modelling of the influence of polymorphism on blood pressure and antihypertensive therapy.

Heliyon. 2024 Apr 23;10(9):e29988. doi: 10.1016/j.heliyon.2024.e29988. eCollection 2024 May 15.

Mathematical modeling of antihypertensive therapy.

Front Physiol. 2022 Dec 14;13:1070115. doi: 10.3389/fphys.2022.1070115. eCollection 2022.

Reduction of plasma aldosterone and arterial stiffness in obese pre- and stage1 hypertensive subjects after aerobic exercise.

J Hum Hypertens. 2015 Jan;29(1):53-7. doi: 10.1038/jhh.2014.33. Epub 2014 May 1.

The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction.

Vasc Health Risk Manag. 2008;4(5):971-81. doi: 10.2147/vhrm.s3215.